IOM

A recently published expert Perspectives paper from the Institute of Medicine (IOM) proposes an entirely new system for clinicians, researchers, students, trainees, and others to disclose financial relationships that may represent potential conflicts of interest. 

[Read the rest of this article...]

ASCO and the Institute of Medicine plan to host a workshop Feb. 11-12, 2013, on the continuing efforts to reorganize the nation’s federally-funded cancer clinical trials cooperative group system overseen by the U.S. National Cancer Institute.

[Read the rest of this article...]

Allen S. Lichter, MD, chief executive officer of ASCO, underscored the importance of the oncology community to work together in order to improve the quality of cancer care.

[Read the rest of this article...]

As part of the Institute of Medicine’s (IOM) National Cancer Policy Forum (NCPF) workshop on delivering affordable cancer care in the 21^st century, ASCO’s Top Five list was highlighted as an example of ways to improve quality of care for patients while reducing unnecessary costs.

[Read the rest of this article...]

A recent report by the Institute of Medicine addresses elements that ASCO has stated are necessary for transforming the therapeutic development and cl...

[Read the rest of this article...]

ASCO CEO Allen S. Lichter, MD, will participate in a panel discussion on potentially new research models and pathways at a National Cancer Policy Foru...

[Read the rest of this article...]

ASCO continues to work with the National Cancer Institute and other stakeholders on the implementation of recommendations of the 2010 Institute of Med...

[Read the rest of this article...]

A new ASCO report analyzes progress in restructuring of the National Cancer Institute's Clinical Trials Cooperative Group Program and implem...

[Read the rest of this article...]